查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362867

HIV 诊断市场规模、份额、趋势分析报告：按产品、测试类型、模式、最终用途、地区和细分市场预测，2023-2030 年

HIV Diagnostics Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test Type (Antibody Tests, Viral Load Tests), By Mode (Self-Test, Lab-based), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

HIV诊断市场的成长和趋势

Grand View Research, Inc. 的一项新研究显示，到 2030 年，全球爱滋病毒诊断市场预计将达到 15.5017 亿美元，2023 年至 2030 年年复合成长率预计为 5.5%。这一市场成长的主要要素包括开发更灵敏的 HIV 诊断 POC 测试的需求不断增长，这些测试可以在资源有限的环境中轻鬆地在患者护理点进行。在预测期内，检测技术的开拓以及预计推出的大量新型快速POC检测将是推动HIV诊断市场成长的主要要素。此外，政府针对爱滋病毒发起的计划和运动、全球为减少疾病罹患率而开展的医疗保健配合措施、中东和东部地区市场存在的大量未满足的需求都将有利于未来的成长机会。以下是一些预计会发挥作用的关键因素。

HIV 诊断市场报告亮点

  • 抗体测试类型在产业中占据主导地位，2022年占最大收益占有率为53.3%。如此大的份额可以解释为这些测试的高市场使用率和普及，包括 ELISA、家庭访问干血斑、蛋白质印迹测试 IFA 和 RIPA。由于这些检测灵敏且准确，因此最常用于筛检和确认 HIV-1 和 HIV-2。
  • 病毒负担测试和 CD4 测试也将在 2022 年占据相当大的市场。这些检测更加灵敏、快速，并且可以携带到护理点，从而提高了其市场效用和资源匮乏的爱滋病毒感染地区的可及性。
  • 在预测期内，目前正在临床开发和主要市场参与者的产品平臺中的许多新型即时爱滋病毒诊断产品预计将实现商业化。预计此类产品的增加将在预测期内推动同一市场的成长。
  • 亚太地区占据市场主导地位，2022 年占最大销售份额，达 35.7%。这是由于技术的进步、受爱滋病毒/爱滋病罹患的人数增加以及该地区对爱滋病毒/爱滋病认识的提高。
  • 由于该地区诊断测试意识不断增强，预计拉丁美洲在预测期内将以 6.9% 的年复合成长率增长最快。

目录

第1章调查方法与范围

第2章执行摘要

第3章HIV 诊断市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • HIV 诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章HIV 诊断市场：产品评估与趋势分析

  • HIV诊断市场的要点
  • HIV 诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 消耗品
  • 装置
  • 软体和服务

第5章HIV 诊断市场：模式估计与趋势分析

  • HIV诊断市场的要点
  • HIV 诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 自我测试
  • 实验室基地

第6章HIV 诊断市场：测试类型估计和趋势分析

  • HIV诊断市场的要点
  • HIV 诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 抗体测试
  • 病毒负担测试
  • CD4测试
  • 其他的

第7章HIV 诊断市场：最终用途估计与趋势分析

  • HIV 诊断市场：要点
  • HIV 诊断市场：2022 年和 2030 年趋势和市场占有率分析
  • 诊断实验室
  • 医院和诊所
  • 居家环境
  • 其他的

第8章HIV 诊断市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的爱滋病毒诊断市场：市场要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第9章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Alere Inc.
    • Abbott.
    • Bristol-Myers Squibb Company
    • Janssen Global Service, LLC
    • Gilead Sciences, Inc.
    • Merck & Co. Inc.
    • VIIV Healthcare
    • BD
    • Beckman Coulter, Inc.
    • Sysmex Europe SE
    • Apogee Flow Systems
    • Point Care Technologies Inc.
    • Mylan NV
    • F. Hoffman-La Roche Ltd.
    • Siemens Healthcare GmbH
    • QIAGEN.
Product Code: 978-1-68038-461-1

HIV Diagnostics Market Size Growth & Trends:

The global HIV diagnostics market is expected to reach USD 1550.17 million by 2030, growing at an estimated CAGR of 5.5% from 2023 to 2030, according to a new study by Grand View Research, Inc.. Key factors accounting for the growth of this market include the growing need in for the development of more sensitive HIV diagnostic point of care tests which can be easily implemented at the location of patient care in resource-limited settings. Technological development of tests which is expected to introduce a number of novel rapid, point-of-care tests throughout the forecast period is a primary factor expected to fuel the growth of the HIV diagnostics market. Furthermore, government programs and campaigns initiated against HIV, global healthcare efforts to reduce disease incidence, and the presence of high unmet demand in the Middle Eastern and Eastern regions of the market are some key factors expected to serve as lucrative future growth opportunities.

HIV Diagnostics Market Report Highlights:

  • The antibody test type segment dominated the industry and accounted for the largest revenue share of 53.3% in 2022. This large share can be accounted for by the high market usage and penetration rates of these tests which include, ELISA, home access dried blood spot, western blot testing IFA, and RIPA. These tests are highly sensitive and accurate and thus are most commonly used for screening and confirmation of HIV-1 & HIV-2.
  • Viral Load testing and CD4 testing also accounted for a considerable share of the market in 2022. There is a prevalent in the market for the development of these tests which will make them more sensitive, rapid in nature, and portable to the point of care to enhance their market usability and accessibility in resource-limited HIV-affected regions.
  • It is expected that during the forecast period, a number of novel point-of-care HIV diagnostic products will be commercialized which are currently under clinical development and in product pipelines of key market players. This increase in the range of products is expected to fuel the growth of this market over the forecast period.
  • Asia Pacific dominated the market and accounted for the largest revenue share of 35.7% in 2022 owing to technological advancement, an increase in the number of people suffering from HIV and AIDS, and increasing awareness regarding the same in this region.
  • Latin America is expected to grow at the fastest CAGR of 6.9% during the forecast period owing to the increasing awareness about diagnostic testing in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Mode
    • 1.1.3. Test type
    • 1.1.4. End-use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Mode outlook
    • 2.2.3. Test type
    • 2.2.4. End-use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. HIV Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. HIV Diagnostics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. HIV Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. HIV Diagnostics Market Key Takeaways
  • 4.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Consumables
    • 4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Software And Services
    • 4.5.1. Software and services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. HIV Diagnostics Market: Mode Estimates & Trend Analysis

  • 5.1. HIV Diagnostics Market Key Takeaways
  • 5.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Self-Test
    • 5.3.1. Self-test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lab-Based
    • 5.4.1. Lab-based market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. HIV Diagnostics Market: Test Type Estimates & Trend Analysis

  • 6.1. HIV Diagnostics Market Key Takeaways
  • 6.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Antibody Test
    • 6.3.1. Antibody test market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1. HIV -1 screening market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1.1. ELISA/EIA market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1.2. Home access dried blood spot market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.1.3. Rapid tests (Dot plot, Agglutination tests) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2. HIV-1 antibody confirmatory tests
      • 6.3.1.2.1. Western blot test market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2.2. Indirect Immunofluorescent Antibody Assay (IFA) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2.3. Line immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.2.4. RadioImmunoPrecipitation Assay (RIPA) market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.3. HIV-2 and group O diagnostic tests
      • 6.3.1.3.1. Blood antibody tests market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.3.2. Dried Blood Spot (DBS) test market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.3.1.3.3. Others (Oral, Urine) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Viral Load Test
    • 6.4.1. Viral load test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. CD4 Test
    • 6.5.1. CD4 test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. HIV Diagnostics Market: End-use Estimates & Trend Analysis

  • 7.1. HIV Diagnostics Market: Key Takeaways
  • 7.2. HIV Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Hospitals & Clinics
    • 7.4.1. Hospitals & Clinics Market Estimates and Forecasts, 2018 to 2030 (USD Million)
  • 7.5. Home Settings
    • 7.5.1. Home settings market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. HIV Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. HIV Diagnostics Market by Region: Key Marketplace Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Market Participant Categorization
    • 9.2.1. Alere Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Abbott.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Bristol-Myers Squibb Company
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Janssen Global Service, LLC
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Gilead Sciences, Inc.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Merck & Co. Inc.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. VIIV Healthcare
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. BD
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Beckman Coulter, Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Sysmex Europe SE
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. Apogee Flow Systems
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives
    • 9.2.12. Point Care Technologies Inc.
      • 9.2.12.1. Company overview
      • 9.2.12.2. Financial performance
      • 9.2.12.3. Product benchmarking
      • 9.2.12.4. Strategic initiatives
    • 9.2.13. Mylan N.V.
      • 9.2.13.1. Company overview
      • 9.2.13.2. Financial performance
      • 9.2.13.3. Product benchmarking
      • 9.2.13.4. Strategic initiatives
    • 9.2.14. F. Hoffman-La Roche Ltd.
      • 9.2.14.1. Company overview
      • 9.2.14.2. Financial performance
      • 9.2.14.3. Product benchmarking
      • 9.2.14.4. Strategic initiatives
    • 9.2.15. Siemens Healthcare GmbH
      • 9.2.15.1. Company overview
      • 9.2.15.2. Financial performance
      • 9.2.15.3. Product benchmarking
      • 9.2.15.4. Strategic initiatives
    • 9.2.16. QIAGEN.
      • 9.2.16.1. Company overview
      • 9.2.16.2. Financial performance
      • 9.2.16.3. Product benchmarking
      • 9.2.16.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 4 North America HIV diagnostics Market by test type, 2018 - 2030 (USD Million)
  • Table 5 North America HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America HIV diagnostics market by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. HIV diagnostics Market by product, 2018 - 2030 (USD Million)
  • Table 8 U.S. HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 9 U.S. HIV diagnostics Market by test type, 2018 - 2030 (USD Million)
  • Table 10 U.S. HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada HIV diagnostics market by product, 2018 - 2030 (USD Million)
  • Table 12 Canada HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 13 Canada. HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 14 Canada HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe HIV diagnostics market by product, 2018 - 2030 (USD Million)
  • Table 16 Europe HIV diagnostics market by mode, 2018 - 2030 (USD Million)
  • Table 17 Europe HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 18 Europe HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Germany HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 22 Germany HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 23 Germany HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 UK HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 25 UK HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 26 UK HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 27 UK HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 France HIV diagnostics market, by type, 2018 - 2030 (USD Million)
  • Table 29 France HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 30 France HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 31 France HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 34 Italy HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 35 Italy HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 Spain HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 38 Spain HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 39 Spain HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Sweden HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 41 Sweden HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 42 Sweden HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 43 Sweden HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Norway HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 Norway HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 46 Norway HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 47 Norway HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Denmark HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 49 Denmark HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 50 Denmark HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 51 Denmark HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 57 China HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 China HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 59 China. HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 60 China HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Japan HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 62 Japan HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 63 Japan HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 64 Japan HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 India HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 66 India HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 67 India HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 68 India HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Australia HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Australia HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 71 Australia HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 72 Australia HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Thailand HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 74 Thailand HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 75 Thailand HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 76 Thailand HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 South Korea HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 78 South Korea HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 79 South Korea HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 80 South Korea HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 81 Latin America HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 82 Latin America HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 83 Latin America HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 84 Latin America HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Latin America HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Brazil HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 88 Brazil HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 89 Brazil HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Mexico HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 91 Mexico HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 92 Mexico HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 93 Mexico HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 94 Argentina HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 96 Argentina HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 97 Argentina HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa HIV diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 105 South Africa HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 106 South Africa HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 111 UAE HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 113 UAE HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 114 UAE HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait HIV diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait HIV diagnostics market, by mode, 2018 - 2030 (USD Million)
  • Table 117 Kuwait HIV diagnostics market by test type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait HIV diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 HIV diagnostics: Market outlook

Fig. 9 HIV diagnostics: Competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 HIV diagnostics market driver impact

Fig. 15 HIV diagnostics market restraint impact

Fig. 16 HIV diagnostics market strategic initiatives analysis

Fig. 17 HIV diagnostics market: Product movement analysis

Fig. 18 HIV diagnostics market: Product outlook and key takeaways

Fig. 19 Consumables market estimates and forecasts, 2018 - 2030

Fig. 20 Instruments market estimates and forecasts, 2018 - 2030

Fig. 21 Software and services market estimates and forecasts, 2018 - 2030

Fig. 22 HIV diagnostics market: Mode movement analysis

Fig. 23 HIV diagnostics market: Mode outlook and key takeaways

Fig. 24 Self-test market estimates and forecasts, 2018 - 2030

Fig. 25 Lab-based market estimates and forecasts, 2018 - 2030

Fig. 26 HIV diagnostics market: Test type movement analysis

Fig. 27 HIV diagnostics market: Test type outlook and key takeaways

Fig. 28 Antibody test market estimates and forecasts, 2018 - 2030

Fig. 29 Viral load test market estimates and forecasts, 2018 - 2030

Fig. 30 CD4 test market estimates and forecasts, 2018 - 2030

Fig. 31 Other market estimates and forecasts, 2018 - 2030

Fig. 32 HIV diagnostics market: End-use movement analysis

Fig. 33 HIV diagnostics market: End-use outlook and key takeaways

Fig. 34 Diagnostic laboratories market estimates and forecasts, 2018 - 2030

Fig. 35 Hospitals & clinics market estimates and forecasts, 2018 - 2030

Fig. 36 Home settings market estimates and forecasts, 2018 - 2030

Fig. 37 Other market estimates and forecasts, 2018 - 2030

Fig. 38 Global HIV diagnostics market: Regional movement analysis

Fig. 39 Global HIV diagnostics market: Regional outlook and key takeaways

Fig. 40 North America market estimates and forecasts, 2018 - 2030

Fig. 41 U.S. market estimates and forecasts, 2018 - 2030

Fig. 42 Canada market estimates and forecasts, 2018 - 2030

Fig. 43 Europe. market estimates and forecasts, 2018 - 2030

Fig. 44 UK market estimates and forecasts, 2018 - 2030

Fig. 45 Germany market estimates and forecasts, 2018 - 2030

Fig. 46 France market estimates and forecasts, 2018 - 2030

Fig. 47 Italy market estimates and forecasts, 2018 - 2030

Fig. 48 Spain market estimates and forecasts, 2018 - 2030

Fig. 49 Sweden market estimates and forecasts, 2018 - 2030

Fig. 50 Norway market estimates and forecasts, 2018 - 2030

Fig. 51 Denmark market estimates and forecasts, 2018 - 2030

Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030

Fig. 53 Japan market estimates and forecasts, 2018 - 2030

Fig. 54 China market estimates and forecasts, 2018 - 2030

Fig. 55 India market estimates and forecasts, 2018 - 2030

Fig. 56 Australia market estimates and forecasts, 2018 - 2030

Fig. 57 Thailand market estimates and forecasts, 2018 - 2030

Fig. 58 South Korea market estimates and forecasts, 2018 - 2030

Fig. 59 Latin America market estimates and forecasts, 2018 - 2030

Fig. 60 Brazil market estimates and forecasts, 2018 - 2030

Fig. 61 Mexico market estimates and forecasts, 2018 - 2030

Fig. 62 Argentina market estimates and forecasts, 2018 - 2030

Fig. 63 Middle East and Africa. market estimates and forecasts, 2018 - 2030

Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030

Fig. 65 South Africa market estimates and forecasts, 2018 - 2030

Fig. 66 UAE market estimates and forecasts, 2018 - 2030

Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030